Fair Value Calculator Fair Value Calculator
EN DE

CENLUB (CENLUB) Fair Value & Analysis

IN · Market cap ₹1.0B

C CENLUB CENLUB · BSE
Price₹219.15
Fair Value₹289.16
Upside+31.9%
Quality42/100
Watch CENLUB for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹216.28 – ₹361.45

Fair value as of: Jul 5, 2026

From 16 valuation models · updated yesterday

Share price −3.0% over the past month.

Price vs Fair Value (12 months)

₹439.85 ₹147.25 Fair Value ₹289.16 Jul 2025 Jul 2026

12‑month range ₹147.25 – ₹439.85 · fair‑value band ₹216.28 – ₹361.45 · the ₹219.15 price screens below the ₹289.16 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

CENLUB (CENLUB) currently trades at ₹219.15, while our model-based Fair Value estimate is ₹289.16 — implying the stock looks roughly 31.9% undervalued today. We read business quality at 42/100 (below-average quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, CENLUB generated revenue of ₹741M at a net margin of 10.7%. Revenue grew 11.6% year over year. It earns a return on equity of 11.6%. Net debt stands at ₹108M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹216.28 (bear case) to ₹361.45 (bull case); at ₹219.15, the current price sits within that range. The share trades about 51% below its 52-week high and 60% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹741M
Revenue growth (YoY) +11.6%
Net margin 10.7%
Return on equity 11.6%
Free cash flow −₹125M FY2026
P/E ratio 12.9
More key figures
Operating margin 12.5%
EPS (TTM) ₹17.01
EPS growth (YoY) +27.8%
Net debt ₹108M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

CENLUB reported revenue of ₹741M in FY2026 versus ₹524M in FY2022, a compound +9.0%/yr. Reported net income was ₹79.3M in FY2026, compounding +3.2%/yr from FY2022.

Revenue +9.0%/yr
FY22 ₹524M
FY23 ₹539M
FY24 ₹715M
FY25 ₹734M
FY26 ₹741M
Net income +3.2%/yr
FY22 ₹70.0M
FY23 ₹66.7M
FY24 ₹89.7M
FY25 ₹89.4M
FY26 ₹79.3M

Is CENLUB fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "CENLUB Fair Value". https://www.fairvalue-calculator.com/stock/CENLUB

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is CENLUB (CENLUB) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹289.16 versus a price of ₹219.15 — about +32% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CENLUB?
Our model-based fair value for CENLUB is ₹289.16 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹219.15.
What is the quality score of CENLUB?
CENLUB has a Quality Score of 42/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of CENLUB (CENLUB)?
CENLUB reported trailing-twelve-month revenue of about ₹741M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of CENLUB?
The net profit margin of CENLUB is about 10.7%, meaning it keeps roughly 10.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.